Gland Pharma Limited (GLAND) — Capital Reinvestment Ratio
Latest as of September 2025:
0.33x
Gland Pharma Limited (GLAND) has a Capital Reinvestment Ratio of 0.33x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs5.93 Billion) in capital expenditures (Rs1.94 Billion). See Gland Pharma Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.33x
Capex / Operating Cash Flow
Operating Cash Flow
Rs5.93 Billion
INR
Capital Expenditures
Rs1.94 Billion
INR
Data as of
Sep 2025
Most recent filing
Gland Pharma Limited Capital Reinvestment Ratio (2017–2026)
This chart tracks Gland Pharma Limited's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Gland Pharma Limited (2017–2026)
Year-by-year Capital Reinvestment Ratio for Gland Pharma Limited from 2017 to 2026. For live market cap and broader valuation context, see how much is Gland Pharma Limited worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.40x | Rs12.31 Billion | Rs4.91 Billion | ▼ -5.2% |
| 2025 | 0.42x | Rs9.15 Billion | Rs3.85 Billion | ▲ +7.5% |
| 2024 | 0.39x | Rs9.97 Billion | Rs3.90 Billion | ▼ -36.2% |
| 2023 | 0.61x | Rs3.64 Billion | Rs2.23 Billion | ▼ -7.2% |
| 2022 | 0.66x | Rs7.91 Billion | Rs5.22 Billion | ▲ +74.6% |
| 2021 | 0.38x | Rs6.05 Billion | Rs2.29 Billion | ▲ +36.2% |
| 2020 | 0.28x | Rs7.01 Billion | Rs1.95 Billion | ▼ -62.1% |
| 2019 | 0.73x | Rs1.85 Billion | Rs1.36 Billion | ▲ +73.9% |
| 2018 | 0.42x | Rs2.02 Billion | Rs851.75 Million | ▲ +72.8% |
| 2017 | 0.24x | Rs4.76 Billion | Rs1.16 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow